Codexis Inks Purchase Deal With Nestle Health Science For CDX-7108

RTTNews | vor 588 Tagen
Stocktwits
Codexis Inks Purchase Deal With Nestle Health Science For CDX-7108

(RTTNews) - Enzyme engineering company Codexis, Inc. (CDXS) announced Wednesday it has entered into a purchase agreement with Nestle Health Science for CDX-7108, an investigational therapy for the potential treatment of exocrine pancreatic insufficiency (EPI).

Under the terms of the agreement, Codexis will receive up to $45 million in potential milestone payments, including a $5 million upfront payment, as well as single-digit net-sales-based royalties.

Codexis will receive up to an additional $5 million if Nestle Health Science exercises an option to purchase two additional early-stage enzymes being developed for EPI.

Nestle Health Science will be solely responsible for the continued development and commercialization of CDX-7108, including all associated costs.

Codexis and Nestle Health Science completed pre-clinical work for CDX-7108 and a Phase I clinical trial under the terms of a previous agreement. With this asset purchase agreement, Nestle Health Science may continue advancing the compound through the development process.

Tags: CDXS
Stocktwits
read more
European Economic News Preview: BoE Likely To Cut Rates

European Economic News Preview: BoE Likely To Cut Rates

The Bank of England is widely expected to cut its interest rates for the fifth time in a year to support the economy even as inflation continued to stay stubbornly above the target. Markets anticipate a quarter-point cut, bringing the bank rate to 4.00 percent, which will be the lowest since early 2023.
RTTNews | vor 44 Minuten
European Shares Poised For Mixed Open

European Shares Poised For Mixed Open

European stocks are seen opening on a mixed note Thursday after U.S. President Donald Trump announced he will impose a 100 percent tariff on imports of semiconductors and chips, with exemptions for companies relocating production to the U.S.
RTTNews | vor 1Std 9 Minuten
Sensex, Nifty Open Lower On Tariff Concerns

Sensex, Nifty Open Lower On Tariff Concerns

Indian shares opened a tad lower on Thursday after U.S. President Donald Trump signed an executive order imposing an additional 25 percent tariff on India as a "penalty" in response to its continued purchase of Russian oil.
RTTNews | vor 2Std 17 Minuten
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian market is extending early losses in mid-market moves on Thursday, snapping a three session winning streak, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,850 level, with weakness in iron ore miners and energy stocks.
RTTNews | vor 3Std 13 Minuten
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, despite the broadly positive cues from Wall Street overnight, after U.S. President Donald Trump said the U.S. was closing in on the trade deal with China. Traders also remain optimistic about the US Fed cutting interest rates as early as September based on the recent economic data from the U.S.
RTTNews | vor 3Std 41 Minuten
Thai Stock Market May See Continued Support On Thursday

Thai Stock Market May See Continued Support On Thursday

The Thai stock market has moved higher in three straight sessions, gathering more than 45 points or 3.9 percent along the way. The Stock Exchange of Thailand now sits just beneath the 1,265-point plateau and it's expected to extend its gains again on Thursday.
RTTNews | vor 4Std 44 Minuten
Australia June Trade Surplus A$5.365 Billion

Australia June Trade Surplus A$5.365 Billion

Australia posted a seasonally adjusted merchandise trade surplus of A$5.365 billion in June, the Australian Bureau of Statistics said on Thursday.
RTTNews | vor 4Std 55 Minuten
Tools
Wirtschaftskalender
Handelszeiten
Zinssätze
Feiertagskalender
Forex-Markt
Forex-Volatilität
Forex-Korrelation
Forex-Nachrichten
Forex-Analyse
COT-Daten
Liquidität
Forex-Rechner
Forex Heat-Map
Heatmap der Indikatoren
Community
Community
Systeme
Beliebteste Systeme
Strategien
Wettbewerbe
Forex-Charts
Forex-Sentiment
Prognoseindikator
Bewertungen
Broker
Proprietäre Handelsfirmen
VPS-Dienste
Signalanbieter
EA Programmierdienstleistungen
Affiliate Programs
PAMM - Broker-Dienstleistungen
Rabattprogramm-Dienstleistungen
Handelsplattformen
Expertenberater
Krypto-Börsen
Trading kurse
Broker
Forex-Spreads
Forex-Broker-Kotierungen
Forex-Broker-Swaps
Volumen des Forex-Brokers
Forex-Broker-Aktionen Pressemitteilung
Plattform
Widgets
Funktionen
API
RSS
Stock Portfolio
Affiliate Software
Erweiterte Charts
Betreuung
FAQ
Hilfe
Kontaktieren Sie uns
Fehler melden!
Über uns
Blog
© 2025 Myfxbook Ltd. Alle Rechte vorbehalten.
WARNUNG VOR HOHEM RISIKO: Der Devisenhandel birgt ein hohes Risiko, das möglicherweise nicht für alle Anleger geeignet ist. Der Einsatz von Leverage schafft zusätzliches Risiko und Verlustgefahr. Bevor Sie sich für den Devisenhandel entscheiden, sollten Sie Ihre Anlageziele, Ihr Erfahrungsniveau und Ihre Risikotoleranz sorgfältig prüfen. Sie könnten Ihre ursprüngliche Investition teilweise oder ganz verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren. Informieren Sie sich über die mit dem Devisenhandel verbundenen Risiken und lassen Sie sich von einem unabhängigen Finanz- oder Steuerberater beraten, wenn Sie Fragen haben. Alle Daten und Informationen werden ausschließlich zu Informationszwecken bereitgestellt und sind nicht für Handelszwecke oder Beratung gedacht. Die vergangene Performance ist kein Indikator für zukünftige Ergebnisse.